Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

6 results found.

Example of search result explained

AG-Ticagrelor

Exceptional medication
  • Active ingredient(s):
    ticagrelor
  • Manufactured by:
    Angita Pharma Inc. (Angita)
  • Strength and dosage form:
    Tablet 90 mg DIN : 2537192

Apo-Ticagrelor

Exceptional medication
  • Active ingredient(s):
    ticagrelor
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    Tablet 90 mg DIN : 2482630

Brilinta

Exceptional medication
  • Active ingredient(s):
    ticagrelor
  • Manufactured by:
    AstraZeneca Canada Inc. (AZC)
  • Strength and dosage form:
    Tablet 90 mg DIN : 2368544

JAMP Ticagrelor

Exceptional medication
  • Active ingredient(s):
    ticagrelor
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Tablet 90 mg DIN : 2531801

M-Ticagrelor

Exceptional medication
  • Active ingredient(s):
    ticagrelor
  • Manufactured by:
    Mantra Pharma inc. (Mantra Ph.)
  • Strength and dosage form:
    Tablet 90 mg DIN : 2529769

Taro-Ticagrelor

Exceptional medication
  • Active ingredient(s):
    ticagrelor
  • Manufactured by:
    Taro Pharmaceuticals Inc. (Taro)
  • Strength and dosage form:
    Tablet 90 mg DIN : 2492598
Page 1 of 1

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.